Pricing

Log inSign up

Attralus Therapeutics

0 followers

‌

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Mark Timney
CEO

Mark Timney

Collapse
Spencer Guthrie
Co-Founder & COO
Glen Firestone
Chief Business Officer
Gregory Bell
Chief Medical Officer
Jonathan Wall
Co-Founder & Interim Chief Scientific Officer
James Testa
VP, Finance
Christine Huh
Head, Human Resources
Mike Klein
Senior Vice President, Head of CMC
DC
Dave Conroy
Head of Program Management
Matthew Meldorf
Senior Vice President Clinical Development

Teams

+10

Regulatory and Scientific Development

13 members

+4

Clinical Operations and Development

7 members

+3

Leadership Team

6 members

Offices

Similar companies

Calico

6 followers

Qualigen Therapeutics

3 followers

Vera Therapeutics

2 followers

Cargo

1 follower

Capricor Therapeutics

1 follower

Edgewise Therapeutics

1 follower

Cartesian Therapeutics

1 follower

ADARx Pharmaceuticals

3 followers

Thermo Fisher Scientific

180 followers

Gilead Sciences

136 followers

Biogen

123 followers

Explore companies